Nkarta (NKTX) Other Non-Current Liabilities (2019 - 2026)
Nkarta's (NKTX) quarterly Other Non-Current Liabilities came in at $87000.0 in Q1 2026, little changed year-on-year from $87000.0 in Q1 2025, and little changed quarter-over-quarter from $87000.0 in Q4 2025.
Nkarta (NKTX) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends
Nkarta's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $87000.0 for Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities changed 0.0% year-over-year to $87000.0 in Q1 2026; TTM through Mar 2026 was $87000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $87000.0, changed 0.0% from the prior year.
- Other Non-Current Liabilities was little changed at $87000.0 in Q1 2026 per NKTX's latest filing, from $87000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $87000.0 in Q4 2024 and bottomed at $5000.0 in Q3 2022.
- The 4-year median for Other Non-Current Liabilities is $87000.0 (2024), against an average of $60666.7.
- Across the five-year window, Other Non-Current Liabilities sank 91.07% in 2022 and changed 0.0% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $5000.0 in 2022, then surged by 1640.0% to $87000.0 in 2024, then changed by 0.0% to $87000.0 in 2025, then changed by 0.0% to $87000.0 in 2026.
- Per Business Quant, the three latest NKTX Other Non-Current Liabilities figures stand at $87000.0 (Q1 2026), $87000.0 (Q4 2025), and $87000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 87,000.00 |
| Dec 31, 2025 | 87,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | 87,000.00 |
| Mar 31, 2025 | 87,000.00 |
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 11,000.00 |
| Dec 31, 2021 | 18,000.00 |
| Sep 30, 2021 | 56,000.00 |
| Jun 30, 2021 | 65,000.00 |
| Mar 31, 2021 | 75,000.00 |
| Dec 31, 2020 | 82,000.00 |
| Sep 30, 2020 | 96,000.00 |
| Jun 30, 2020 | 119,963.00 |
| Dec 31, 2019 | 134,000.00 |